CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...
Phase 3
Budapest, Hungary and 161 other locations
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...
Phase 3
Budapest, Hungary and 65 other locations
with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...
Phase 3
Budapest, Hungary and 118 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Budapest, Hungary and 122 other locations
The primary objective of Part 2 is to evaluate the long-term safety of BG00012 in subjects who completed Week 96 in Part 1 of Study 109MS306...
Phase 3
Budapest, Hungary and 61 other locations
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...
Phase 3
Budapest, Hungary and 125 other locations
This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...
Phase 3
Budapest, Hungary and 125 other locations
relapse rate (ARR) in participants with relapsing forms of MSSecondary Objective:To assess efficacy of SAR442168 compared to teriflunomide (...
Phase 3
Budapest, Hungary and 185 other locations
This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple...
Phase 3
Tatabánya, Hungary and 209 other locations
This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...
Phase 3
Budapest, Hungary and 154 other locations
Clinical trials
Research sites
Resources
Legal